Rand Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Rand Wealth’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$2.2M	Hold	18,009	–	–	0.25%	105
2018 Q2	$1.98M	Buy	18,009 +98	+0.5%	+$10.5K	0.22%	109
2018 Q1	$1.91M	Buy	17,911 +51	+0.3%	+$5.65K	0.21%	106
2017 Q4	$1.91M	Sell	17,860 -1,148	-6%	-$123K	0.21%	111
2017 Q3	$2.11M	Hold	19,008	–	–	0.24%	101
2017 Q2	$1.97M	Hold	19,008	–	–	0.27%	102
2017 Q1	$1.86M	Hold	19,008	–	–	0.22%	108
2016 Q4	$1.68M	Buy	19,008 +15,645	+465%	+$1.42M	0.21%	111
2016 Q3	$324K	Hold	3,363	–	–	0.04%	191
2016 Q2	$288K	Hold	3,363	–	–	0.04%	196
2016 Q1	$292K	Hold	3,363	–	–	0.04%	192
2015 Q4	$379K	Sell	3,363 -759	-18%	-$82.4K	0.05%	181
2015 Q3	$417K	Hold	4,122	–	–	0.06%	175
2015 Q2	$507K	Hold	4,122	–	–	0.07%	160
2015 Q1	$472K	Buy	4,122 +168	+4%	+$18.5K	0.06%	167
2014 Q4	$432K	Hold	3,954	–	–	0.06%	176
2014 Q3	$361K	Buy	3,954 +1,179	+42%	+$103K	0.05%	169
2014 Q2	$238K	Sell	2,775 -1,179	-30%	-$92.9K	0.03%	188
2014 Q1	$312K	Hold	3,954	–	–	0.05%	165
2013 Q4	$299K	Sell	3,954 -4,473	-53%	-$317K	0.05%	167
2013 Q3	$589K	Hold	8,427	–	–	0.12%	133
2013 Q2	$488K	Buy	+8,427	New	+$487K	0.11%	134

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rand Wealth's IBB Position: Q3 2018 in Review

Rand Wealth held its iShares Biotechnology ETF (IBB) position steady in Q3 2018 at 18,009 shares worth $2.2M. The position accounts for 0.25% of the portfolio, ranked #105.

Rand Wealth first reported a position in IBB in Q2 2013 and has held it in 22 quarters since. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

Rand Wealth held 18,009 shares of iShares Biotechnology ETF worth $2.2M as of Q3 2018.
Rand Wealth left its iShares Biotechnology ETF share count unchanged in Q3 2018.
iShares Biotechnology ETF made up 0.25% of Rand Wealth's portfolio in Q3 2018, its #105 holding.
Rand Wealth first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 22 quarters since.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.